Abstract
SIRT1, an NAD-dependent histone/protein deacetylase, has classically been thought of as a nuclear protein. In this study, we demonstrate that SI RT1 is mainly localized in the nucleus of nor mal cells, but is predominantly localized in the cytopl as m of t he cancer / transformed cell s we tested. We found this predominant cytoplasmic localization of SIRT1 is regulated by elevated mitotic activity and PI3K/IGF-1R signaling in cancer cells. We show that aberrant cytoplasmic localization of SIRT1 is due to increased protein stability and is regulated by PI3K/IGF-1R signaling. In addition, we determined that SIRT1 is required for PI3K-mediated cancer cell growth. Our study represents the first identification that aberrant cytoplasm localization is one of the specific alternations to SIRT1 that occur in cancer cells, and PI3K/IGF-1R signaling plays an important role in the regulation of cytoplasmic SIRT1 stability. Our findings suggest that the over-expressed cytoplasmic SIRT1 in cancer cells may greatly contribute to its cancer-specific functionb y working downstream of the PI 3K/I GF -1R signaling pathway. © Ivyspring International Publisher.
Author supplied keywords
Cite
CITATION STYLE
Byles, V., Chmilewski, L. K., Wang, J., Zhu, L., Forman, L. W., Faller, D. V., & Dai, Y. (2010). Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. International Journal of Biological Sciences, 6(6), 599–612. https://doi.org/10.7150/ijbs.6.599
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.